ONL Therapeutics announced the first patient has been randomized in its phase 2 GALAXY ( NCT06659445) trial evaluating ...

Xelafaslatide is an investigational first-in-class small molecule Fas inhibitor designed to protect key retinal cells, including photoreceptors, from cell death that occurs across a range of retinal ...

Yeast doesn’t know it’s making humanity’s favorite molecule. In this episode, we explore how chemistry turns fruit juice into Friday night.

Ever wondered what “artificial vanilla” actually means? In this episode, we take vanilla extract to chemistry class, chase down the molecule that smells like comfort and maybe discover too much about ...

Ebola is one of the nasty viruses that can hide in the body even after a patient recovers and tests negative. It can reemerge and trigger a new outbreak years later. How do they survive? And how can ...

Roche has dropped five Chugai candidates from its clinical pipeline, echoing actions the Japanese business took earlier this ...